lysine has been researched along with Congenital Myasthenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreux, F; Barois, A; Bauché, S; Eymard, B; Fardeau, M; Fournier, E; Gaudon, K; Hainque, B; Hantaï, D; Ioos, C; Koenig, J; Leroy, JP; Mayer, M; Mokhtari, M; Prioleau, C; Richard, P; Routon, MC; Yasaki, E | 1 |
| Abicht, A; Baumeister, SK; Beeson, D; Burke, G; Cossins, J; Eymard, B; Hantaï, D; Lochmüller, H; Müller, JS; Richard, P; Stucka, R | 1 |
2 other study(ies) available for lysine and Congenital Myasthenia
| Article | Year |
|---|---|
Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.
Topics: Adult; Amino Acid Substitution; Asparagine; Child; Child, Preschool; Female; Founder Effect; Humans; Infant; Lysine; Male; Muscle Proteins; Mutation; Myasthenic Syndromes, Congenital; Pedigree; Receptors, Nicotinic | 2003 |
The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder.
Topics: Asparagine; Europe; Evolution, Molecular; Founder Effect; Humans; India; Lysine; Muscle Proteins; Mutation, Missense; Myasthenic Syndromes, Congenital | 2004 |